Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Buzz on the Bullboards: The Fast Movers & the Up-and-Comers

On Buzz on the Bullboards, we normally provide the Stockhouse Community with a snapshot of recent Bullboard activity, often accompanied by an Investor Pulse Poll – providing you with information on current sentiment. It has been generally difficult for energy companie...

Buzz on the Bullboards: Buying Binge or Sell-Off Frenzy?

Adrift in a sea of global economic uncertainty and confusion, last week was full of tough questions for investors on the Stockhouse Bullboards. Some of the most popular companies on the website suffered setbacks, while other small caps gained attention as investors looked...

Buzz on the Bullboards: The Top Last-Minute Movers of 2021

Expecting the markets to be relaxed heading into the holidays? Hardly. Many investors and brokers know that this is the time to shine. With every twist and turn the global economy has been throwing our way, the right move is staying active. This past week, it seems ma...

Unique Value-Added Antiviral Vaccine Technology Platform

(Click to play video.) Founded in 2018 to improve on protein haptenization and leverage previous vaccine development in the field, Vancouver, BC-based BioVaxys Technology Corp . ( CSE.BIOV , OTCQB: BVAX , Forum ) is a clinical stage biotechnology company that...

Why There is Still a Dire Need for COVID-19 Testing

(Click image to play video) While the tide has turned in many countries in battle against the COVID-19, the global pandemic is far from over in countries like India, for example. Thus, the need for quick, reliable COVID at-home testing is still existential. T...

True Leaf Brands Creates Path to Market for BC Craft Cannabis

Licensed producer True Leaf is zeroing in on an enormous opportunity - capturing consumers from the multi-billion-dollar grey market. Spending on cannabis products in the third quarter of last year reached $824 million (CAD) while unlicensed sales, according to many ...

How This Company is Tapping Into the Growing Cannabis Vaping Market

(Click image to watch video) Cannabis vape products, in particular, have been gaining traction as legalization of the recreational drug becomes more widespread in certain U.S. states. Case in point, it is estimated that in states like California, Colorado, Ne...

Buzz on the Bullboards: COVID & Cannabis plays, Oil & Hurricanes

From short-term energy plays, to long-term industrial bets, and even uncertain cannabis swings, small-cap investors have had their hands full over these last few months keeping up with the markets in these COVID times … the latest hot play is ever changing. Even...

Enochian Shares Trade Up 50% upon Concluding FDA Meeting for Potential HIV Cure

Shares of Enochian Biosciences reached a new 52-week high after the company reported that it successfully completed its FDA INTERACT meeting for ENOB-HV-01, a potential cure for HIV. Gene-modified cellular and immune therapies company Enochian Biosciences Inc. (EN...

MyoKardia Shares Get a Jolt from Positive Phase 3 HCM Clinical Trial Results

Shares of MyoKardia traded 60% higher, setting a new 52-week high price, after the company reported that it met all primary and secondary endpoints in the Phase 3 EXPLORER study of mavacamten in treatment of obstructive hypertrophic cardiomyopathy. Clinical-...
1 2 3